During the recent years, Hitco Holding has managed to focus on development of patient centric solutions, especially those which requires the expertise of local, Iranians young professionals. In line with the overall policy, this group has successfully launched a frameworks of operation, to represent and supply moste innovative solutions in crucial therapeutic areas, such as cancer, diabates and several other neurological products. To deliver further, the HITCO Group remains intensively engaged with scientific patient associations, academic influential figures, and universities.
